TD Capital Management
ABBV icon

TD Capital Management’s AbbVie ABBV Stock Holding History

TD Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$206K Buy
788
+4
+0.5% +$1.02K 0.02% 142
2026
Q2 		$197K Buy
784
+6
+0.8% +$1.29K 0.02% 143
2026
Q1 		$169K Sell
778
-44
-5% -$9.8K 0.02% 147
2025
Q4 		$188K Buy
822
+137
+20% +$31.2K 0.02% 129
2025
Q3 		$159K Buy
685
+5
+0.7% +$1.02K 0.01% 138
2025
Q2 		$126K Buy
680
+552
+431% +$103K 0.01% 146
2025
Q1 		$26.8K Buy
128
+58
+83% +$11.3K ﹤0.01% 231
2024
Q4 		$12.5K Buy
70
+16
+30% +$2.94K ﹤0.01% 272
2024
Q3 		$10.8K Hold
54
– – ﹤0.01% 284
2024
Q2 		$9.27K Hold
54
– – ﹤0.01% 283
2024
Q1 		$9.7K Buy
54
+1
+2% +$172 ﹤0.01% 286
2023
Q4 		$8.22K Sell
53
-340
-87% -$49.6K ﹤0.01% 296
2023
Q3 		$58.5K Buy
393
+4
+1% +$587 0.01% 161
2023
Q2 		$52.4K Buy
389
+3
+0.8% +$440 0.01% 171
2023
Q1 		$61.4K Sell
386
-21
-5% -$3.21K 0.01% 161
2022
Q4 		$65.7K Buy
407
+29
+8% +$4.45K 0.01% 144
2022
Q3 		$51K Buy
+378
New +$54.2K 0.01% 159
2022
Q1 		– Sell
-439
Closed -$59K – 95
2021
Q4 		$59K Sell
439
-106
-19% -$12.5K 0.01% 152
2021
Q3 		$59K Buy
545
+4
+0.7% +$457 0.01% 145
2021
Q2 		$61K Buy
541
+5
+0.9% +$563 0.01% 135
2021
Q1 		$58K Buy
536
+126
+31% +$13.5K 0.01% 130
2020
Q4 		$44K Buy
410
+5
+1% +$480 0.01% 135
2020
Q3 		$35K Buy
+405
New +$38.1K 0.01% 133
2019
Q3 		– Sell
-455
Closed -$33K – 259
2019
Q2 		$33K Buy
+455
New +$35.8K 0.01% 123
2017
Q4 		– Sell
-112
Closed -$10K – 183
2017
Q3 		$10K Buy
+112
New +$8.53K ﹤0.01% 134

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

TD Capital Management's ABBV Position: Q3 2026 in Review

TD Capital Management increased its AbbVie (ABBV) stake by 0.51% in Q3 2026, buying an estimated $1.02K and bringing the position to 788 shares worth $206K. The position accounts for 0.02% of the portfolio, ranked #142.

TD Capital Management first reported a position in ABBV in Q3 2017 and has held it in 25 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • TD Capital Management held 788 shares of AbbVie worth $206K as of Q3 2026.
  • TD Capital Management bought 4 AbbVie shares in Q3 2026, an estimated $1.02K.
  • AbbVie made up 0.02% of TD Capital Management's portfolio in Q3 2026, its #142 holding.
  • TD Capital Management first reported a position in AbbVie in Q3 2017 and has held it in 25 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on TD Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.